A股異動丨匯川技術(300124.SZ)大漲逾10%破頂 市值近1900億元
格隆匯2月8日丨匯川技術(300124.SZ)拉昇至10.24%,盤中高見111元創歷史新高,成交額放大至14.9億元,總市值近1900億元。近年來,匯川技術除了在其主營的工業自動化領域取得較大進展外,在工業機器人、新能源乘用車等領域的收入也實現了快速增長。在過去的一年裏,公司新能源汽車業務增長最為顯著,銷售收入同比增長 85.31%,其工業機器人業務也實現了銷售收入同比增長70.63%的好成績。近2個月該股不斷攀升,從高瓴資本2020年11月1日調研匯川技術至今,股價漲幅已達到了70%。據統計數據顯示,去年12月,機構調研個股數量有370多隻,匯川技術成為調研機構數量最多的公司,合計有272家機構調研了該公司。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.